150 related articles for article (PubMed ID: 37935523)
1. FIGO 2023 endometrial cancer staging: too much, too soon?
McCluggage WG; Bosse T; Gilks CB; Howitt BE; McAlpine JN; Nucci MR; Rabban JT; Singh N; Talia KL; Parra-Herran C
Int J Gynecol Cancer; 2023 Nov; ():. PubMed ID: 37935523
[TBL] [Abstract][Full Text] [Related]
2. Endometrial cancer risk factors, treatment, and survival outcomes as per the European Society for Medical Oncology (ESMO) - European Society of Gynaecological Oncology (ESGO) - European Society for Radiotherapy and Oncology (ESTRO) risk groups and International Federation of Gynecology and Obstetrics (FIGO) staging: An experience from developing world.
Gupta N; Pandey A; Dimri K; Sehgal A; Bhagat R; Suraj ; Gill G
J Cancer Res Ther; 2023; 19(3):701-707. PubMed ID: 37470597
[TBL] [Abstract][Full Text] [Related]
3. Perceptions of Controversies and Unresolved Issues in the 2014 FIGO Staging System for Endometrial Cancer: Survey Results From Members of the International Society of Gynecological Pathologists and International Gynecologic Cancer Society.
Kayraklioglu N; Katsakhyan L; Cohen PA; Singh N; Rabban JT; Matias-Guiu X
Int J Gynecol Pathol; 2024 May; 43(3):242-252. PubMed ID: 37668357
[TBL] [Abstract][Full Text] [Related]
4. FIGO staging of endometrial cancer: 2023.
Berek JS; Matias-Guiu X; Creutzberg C; Fotopoulou C; Gaffney D; Kehoe S; Lindemann K; Mutch D; Concin N;
Int J Gynaecol Obstet; 2023 Aug; 162(2):383-394. PubMed ID: 37337978
[TBL] [Abstract][Full Text] [Related]
5. Preoperative MR imaging for ESMO-ESGO-ESTRO classification of endometrial cancer.
Lavaud P; Fedida B; Canlorbe G; Bendifallah S; Darai E; Thomassin-Naggara I
Diagn Interv Imaging; 2018 Jun; 99(6):387-396. PubMed ID: 29472031
[TBL] [Abstract][Full Text] [Related]
6. New staging of endometrial carcinoma - FIGO 2023.
Hruda M; Sehnal B; Halaška MJ; Drozenová J; Robová H; Pichlík T; Rob L
Ceska Gynekol; 2024; 89(2):120-127. PubMed ID: 38704224
[TBL] [Abstract][Full Text] [Related]
7. The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients with Cervical Cancer.
Cibula D; Pötter R; Planchamp F; Avall-Lundqvist E; Fischerova D; Haie-Meder C; Köhler C; Landoni F; Lax S; Lindegaard JC; Mahantshetty U; Mathevet P; McCluggage WG; McCormack M; Naik R; Nout R; Pignata S; Ponce J; Querleu D; Raspagliesi F; Rodolakis A; Tamussino K; Wimberger P; Raspollini MR
Virchows Arch; 2018 Jun; 472(6):919-936. PubMed ID: 29725757
[TBL] [Abstract][Full Text] [Related]
8. ESGO/ESTRO/ESP Guidelines for the management of patients with endometrial carcinoma.
Concin N; Creutzberg CL; Vergote I; Cibula D; Mirza MR; Marnitz S; Ledermann JA; Bosse T; Chargari C; Fagotti A; Fotopoulou C; González-Martín A; Lax SF; Lorusso D; Marth C; Morice P; Nout RA; O'Donnell DE; Querleu D; Raspollini MR; Sehouli J; Sturdza AE; Taylor A; Westermann AM; Wimberger P; Colombo N; Planchamp F; Matias-Guiu X
Virchows Arch; 2021 Feb; 478(2):153-190. PubMed ID: 33604759
[TBL] [Abstract][Full Text] [Related]
9. Endometrial Carcinoma Diagnosis: Use of FIGO Grading and Genomic Subcategories in Clinical Practice: Recommendations of the International Society of Gynecological Pathologists.
Soslow RA; Tornos C; Park KJ; Malpica A; Matias-Guiu X; Oliva E; Parkash V; Carlson J; McCluggage WG; Gilks CB
Int J Gynecol Pathol; 2019 Jan; 38 Suppl 1(Iss 1 Suppl 1):S64-S74. PubMed ID: 30550484
[TBL] [Abstract][Full Text] [Related]
10. Verification of the prognostic precision of the new 2023 FIGO staging system in endometrial cancer patients - An international pooled analysis of three ESGO accredited centres.
Schwameis R; Fanfani F; Ebner C; Zimmermann N; Peters I; Nero C; Marth C; Ristl R; Leitner K; Grimm C; Oberndorfer F; Capasso I; Zeimet AG; Polterauer S; Scambia G; Fagotti A; Concin N
Eur J Cancer; 2023 Nov; 193():113317. PubMed ID: 37748967
[TBL] [Abstract][Full Text] [Related]
11. ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma.
Concin N; Matias-Guiu X; Vergote I; Cibula D; Mirza MR; Marnitz S; Ledermann J; Bosse T; Chargari C; Fagotti A; Fotopoulou C; Martin AG; Lax S; Lorusso D; Marth C; Morice P; Nout RA; O'Donnell D; Querleu D; Raspollini MR; Sehouli J; Sturdza A; Taylor A; Westermann A; Wimberger P; Colombo N; Planchamp F; Creutzberg CL
Radiother Oncol; 2021 Jan; 154():327-353. PubMed ID: 33712263
[TBL] [Abstract][Full Text] [Related]
12. ESGO/ESHRE/ESGE Guidelines for the fertility-sparing treatment of patients with endometrial carcinoma
Rodolakis A; Scambia G; Planchamp F; Acien M; Di Spiezio Sardo A; Farrugia M; Grynberg M; Pakiz M; Pavlakis K; Vermeulen N; Zannoni G; Zapardiel I; Macklon KLT
Hum Reprod Open; 2023; 2023(1):hoac057. PubMed ID: 36756380
[TBL] [Abstract][Full Text] [Related]
13. The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology guidelines for the management of patients with cervical cancer.
Cibula D; Pötter R; Planchamp F; Avall-Lundqvist E; Fischerova D; Haie Meder C; Köhler C; Landoni F; Lax S; Lindegaard JC; Mahantshetty U; Mathevet P; McCluggage WG; McCormack M; Naik R; Nout R; Pignata S; Ponce J; Querleu D; Raspagliesi F; Rodolakis A; Tamussino K; Wimberger P; Raspollini MR
Radiother Oncol; 2018 Jun; 127(3):404-416. PubMed ID: 29728273
[TBL] [Abstract][Full Text] [Related]
14. Current FIGO Staging for Carcinoma of the Cervix Uteri and Treatment of Particular Stages.
Sehnal B; Kmoníčková E; Sláma J; Tomancová V; Zikán M
Klin Onkol; 2019; 32(3):224-231. PubMed ID: 31216857
[TBL] [Abstract][Full Text] [Related]
15. Impact of the 2023 FIGO Staging System for Endometrial Cancer on the Use of Imaging Services: An Indian Perspective.
Chandramohan A; Manchanda S; Renganathan R; Popat PB; Shah D; Dhamija E; Sen A
Indian J Radiol Imaging; 2024 Apr; 34(2):309-323. PubMed ID: 38549900
[TBL] [Abstract][Full Text] [Related]
16. Integrated clinicopathologic and molecular analysis of endometrial carcinoma: Prognostic impact of the new ESGO-ESTRO-ESP endometrial cancer risk classification and proposal of histopathologic algorithm for its implementation in clinical practice.
de Biase D; Maloberti T; Corradini AG; Rosini F; Grillini M; Ruscelli M; Coluccelli S; Altimari A; Gruppioni E; Sanza V; Turchetti D; Galuppi A; Ferioli M; Giunchi S; Dondi G; Tesei M; Ravegnini G; Abbati F; Rubino D; Zamagni C; De Iaco P; Santini D; Ceccarelli C; Perrone AM; Tallini G; De Leo A
Front Med (Lausanne); 2023; 10():1146499. PubMed ID: 37064027
[TBL] [Abstract][Full Text] [Related]
17. Identification of
Beinse G; Rance B; Just PA; Izac B; Letourneur F; Saidu NEB; Chouzenoux S; Nicco C; Goldwasser F; Batteux F; Durdux C; Chapron C; Pasmant E; Leroy K; Alexandre J; Borghese B
Int J Gynecol Cancer; 2020 May; 30(5):640-647. PubMed ID: 32169874
[TBL] [Abstract][Full Text] [Related]
18. ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma.
Concin N; Matias-Guiu X; Vergote I; Cibula D; Mirza MR; Marnitz S; Ledermann J; Bosse T; Chargari C; Fagotti A; Fotopoulou C; Gonzalez Martin A; Lax S; Lorusso D; Marth C; Morice P; Nout RA; O'Donnell D; Querleu D; Raspollini MR; Sehouli J; Sturdza A; Taylor A; Westermann A; Wimberger P; Colombo N; Planchamp F; Creutzberg CL
Int J Gynecol Cancer; 2021 Jan; 31(1):12-39. PubMed ID: 33397713
[TBL] [Abstract][Full Text] [Related]
19. Further refining 2020 ESGO/ESTRO/ESP molecular risk classes in patients with early-stage endometrial cancer: A propensity score-matched analysis.
Nero C; Pasciuto T; Cappuccio S; Corrado G; Pelligra S; Zannoni GF; Santoro A; Piermattei A; Minucci A; Lorusso D; Fanfani F; Scambia G
Cancer; 2022 Aug; 128(15):2898-2907. PubMed ID: 35617463
[TBL] [Abstract][Full Text] [Related]
20. The central role of the pathologist in the management of patients with cervical cancer: ESGO/ESTRO/ESP guidelines.
Raspollini MR; Lax SF; McCluggage WG
Virchows Arch; 2018 Jul; 473(1):45-54. PubMed ID: 29799071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]